Assessment for Acquired Pyruvate Kinase Deficiency
Characterization Of Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
What's the purpose of the trial?
This cross-sectional prevalence assessment study involves a single blood draw in specific patient populations to assess for enzymatic and genomic evidence for acquired pyruvate kinase deficiency.
Trial status
Accepting patients
Phase
Observational Trial
Enrollment
100
Last Updated
3 months ago
Participating Centers
There is one center participating in this trial. Enter a location below to view the distance.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.